Dapaglyn 5 Tablet
Marketer
Zydus Cadila
Salt Composition
Dapagliflozin (5mg)
Overview Dapaglyn 5 Tablet
Saxagliptin 5 mg tablets are indicated for managing type 2 diabetes, either independently or as part of a combination therapy. This medication assists in regulating elevated blood glucose, thereby minimizing the risk of severe diabetic complications and contributing to cardiovascular protection. Saxagliptin 5 mg can be administered with or without food, consistently at the same time daily, as determined by your physician. Discontinuing the medication without consulting your doctor is strongly discouraged, as this could lead to a rise in blood sugar and potentially serious consequences such as renal impairment and vision loss. This drug forms one component of a comprehensive diabetes management plan that must incorporate a healthy diet, regular physical activity, and weight management as advised by your doctor. Commonly reported side effects encompass vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. The medication may induce excessive fluid loss; therefore, adequate hydration is crucial to prevent dehydration. Practicing good hygiene can help prevent genital fungal infections. Prior to commencing treatment, patients should inform their doctor of any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or lactating individuals require medical consultation before initiating Saxagliptin 5 mg. Excessive alcohol consumption should be avoided due to the potential for heightened side effect risk. Regular blood glucose monitoring is essential throughout treatment.
Uses of Dapaglyn 5 Tablet
Managing type 2 diabetes
Major Benefits of Dapaglyn 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapaglyn 5 Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Dapaglyn 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaglyn 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Dapaglyn 5 Tablets can be ingested with or without food, though consistent timing is recommended.
How Dapaglyn 5 Tablet works:
Dapagliflozin 5 mg tablets are used to manage type 2 diabetes. They function by increasing the excretion of glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapaglyn 5 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapaglyn 5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Dapaglyn 5mg tablets are likely incompatible. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should not take Dapaglyn 5mg tablets; use is contraindicated. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment can safely use Dapaglyn 5 mg tablets without requiring a modification to the prescribed dosage.
What if you forget to take Dapaglyn 5 Tablet :
Should you forget a Dapaglyn 5 Tablet dose, take it immediately if you remember. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapaglyn 5 Tablet
Label | Value |
---|---|
Chemical Type | Phenolic Glycoside Derivative |
Developing Habits | No. |
Treatment Category | Diabetes medication |
Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |